Investing.com - Renalytix AI Nas reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Renalytix AI Nas announced earnings per share of $-0.32 on revenue of $969K. Analysts polled by Investing.com EPS of $-0.16 on revenue of $1.1M.
Renalytix AI Nas 's are down 88% and is trading at $1.88 , still down 90.50% from its 52 week high of $19.79 set on Thursday, December 2, 2021.
Renalytix AI Nas follows other major Healthcare sector earnings this month
Renalytix AI Nas's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, EPS of $1.91 on revenue of $6.91B.
Novo Nordisk ADR had beat expectations on Wednesday, November 2, 2022 with third quarter EPS of $0.8409 on revenue of $6.04B, for EPS of $0.837 on revenue of $6.04B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar